Nomura Holdings, Inc.

NYSE:NMR

Financial - Capital Markets

Financial Services
$9.23 -1.32%

-$0.12 today

Market cap
$27.29B
Beta
0.61
P/E (TTM)
0.3
EPS (TTM)
$4,986.67
Dividend yield
3.55%
52W Low $6.02High $9.58

Volume 3.51M

Average 1.75M

NMR EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Nomura Holdings, Inc.NYSE: NMR

EBITDA · Q1 FY2027 · quarter ended Jun 2026

EBITDA growth accelerates

Q1 FY2027 EBITDA of ¥211.54B rose 32.0% year over year, ahead of the +15.3% change in trailing-twelve-month EBITDA. Sequentially, it rose 66.5% from the prior quarter. Over 3 fiscal years it compounded at +42.3% a year.

Context

  • EBITDA amounted to 12.8% of revenue in FY2026, up 0.9 pp from a year earlier.
  • EBITDA increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 2 analysts of ¥836.03B (+37.5%) for the fiscal year ending Mar 2027, a step up from the +14.0% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
¥211.54B+66.5% QoQ
Last fiscal yearMar 2026
¥608.09B+14.0% YoY
LTMJun 2026
¥610.47B+15.3% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+32.0%——
1 year+14.0%+37.5%+23.5 pp
3-year CAGR+42.3%+13.8%-28.5 pp
5-year CAGR+13.2%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

JPY · from the income statement

Latest · FY2026
608.09B JPY
Year-over-year change
+14.0%
4-year CAGR
+20.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How NMR compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +15.3% is the 5th highest of 9, against a peer median of +27.0%.
  • EBITDA amounts to 14.1% of revenue for NMR, versus a peer median of 22.5%.
NMR Competitors
EBITDA for NMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NMRNomura Holdings, Inc.LTM Jun 2026¥610.47B JPY+15.3%+42.3%14.1%
GSThe Goldman Sachs Group, Inc.LTM Sep 2026$33.01B USD+41.0%+14.7%26.7%
MSMorgan StanleyLTM Sep 2026$29.65B USD+12.9%+13.7%22.9%
UBSUBS Group AGLTM Jun 2026$21.15B USD+97.9%+4.2%27.8%
JEFJefferies Financial Group Inc.LTM Aug 2026$2.35B USD-37.6%-23.7%18.8%
SFStifel Financial Corp.LTM Sep 2026$1.96B USD+115.2%+0.4%29.3%
EVREvercore Inc.LTM Jun 2026$1.05B USD+73.2%+3.2%22.2%
LAZLazard LtdLTM Sep 2026$358.38M USD-23.9%-13.8%10.6%
OPYOppenheimer Holdings Inc.LTM Mar 2026$264.51M USD+12.1%+44.8%15.4%
Peer median (excluding NMR) —+27.0%+3.7%22.5%

Competitors are the stored peer set for NMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

JPY
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue1.37T2.3T3.97T4.51T4.76T
Cost of Revenue230.11B1.15T2.6T2.84T2.59T
Gross Profit1.14T1.14T1.38T1.66T2.17T
Gross Margin83.3%49.9%34.7%36.9%45.6%
Research & Development00000
Selling, General & Admin529.51B605.79B673.52B732.39B1.37T
Operating Expenses917.09B995.5B1.1T1.19T1.63T
Depreciation & Amortization59.52B61.42B61.34B61.65B68.27B
EBITDA286.15B210.9B335.19B533.62B608.09B
EBITDA Margin20.8%9.2%8.4%11.8%12.8%
Operating Income226.62B149.47B273.85B471.96B539.82B
Operating Margin16.5%6.5%6.9%10.5%11.3%
Interest Income284.22B1.11T2.62T2.93T2.67T
Interest Expense230.11B1.15T2.6T2.84T2.59T
Other Income / Expenses00000
Income Before Tax226.62B149.47B273.85B471.96B539.82B
Pre-Tax Margin16.5%6.5%6.9%10.5%11.3%
Income Tax Expense80.09B57.8B96.63B124.71B165.44B
Net Income143B92.79B165.86B340.74B362.13B
Net Margin10.4%4.0%4.2%7.6%7.6%
EPS (Basic)46.6830.8654.97115.30123.08
EPS (Diluted)45.2329.7452.75111.03118.99
Weighted Avg Shares3.06B3.01B3.02B2.96B2.94B
Weighted Avg Shares (Diluted)3.16B3.11B3.14B3.07B3.04B

Nomura Holdings, Inc.

NYSE:NMR

Intrinsic Alpha fair value

Locked

Current Price

$9.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.